Findings from a 3 year analysis of CanScreen5, a world-wide cancer screening data repository with contributions from 84 countries and launched by the International Agency for Research on Cancer (IARC) were recently published in Nature Medicine. Focusing on screening programs for breast, cervical, and colorectal cancer, CanScreen5 unveiled "large variability...regarding compliance to further assessment of screening programmes and detection rates reported for precancerous and cancers." Screening coverage for breast cancer ranged from 1.7% in Bangladesh to 85.5% in England; for cervical cancer screening, programs range from 2.1% in the Ivory Coast to 86.3% for Sweden, while colorectal cancer screening programs ranged from 0.6% in Hungary to 64.5% in the Netherlands.
To read more about the CanScreen5 study, click here.
Sources mentioned:
Zhang L, Mosquera I, Lucas E, et al. & CanScreen5 collaborators. CanScreen5, a global repository for breast, cervical and colorectal cancer screening programs. Nature Medicine; Published online 27 April 2023. DOI: https://doi.org/10.1038/s41591-023-02315-6
Wang F, Dong X, Li N. A call to improve the quality of screening programs. Nature Medicine; Published online 27 April 2023. DOI: https://doi.org/10.1038/s41591-023-02305-8
No comments:
Post a Comment